ESCMID is concerned that a lack of evidence-based information among healthcare providers and the lay public may undermine the efficacy of future vaccination campaigns. As part of its multidisciplinary approach to fight infections, ESCMID is committed to improve the scientific basis for vaccines and optimize their use in the healthcare setting. This conference is set to bring together leading experts who will present and debate the most recent data to develop strategies that will help protect generations to come from vaccine-preventable diseases.

Specialists or physicians in training in infectious diseases, clinical microbiology, hygiene, public health, vaccinology and other disciplines dealing with all aspects of vaccination.

Robb Butler, Copenhagen, Denmark
Ron Dagan, Beer Sheva, Israel
Susanna Esposito, Perugia, Italy
Lucia Pastore Celentano, Stockholm, Sweden
Mario Poljak, Ljubljana, Slovenia
ESCMID Vaccine Study Group - EVASG
The organizer(s) of the course will apply for European CME accreditation through EACCME.


Ananda Bandyopadhyay, Seattle, United States
Paolo Bonanni, Rome, Italy
Louis Bont, Utrecht, Netherlands
Tammy Boyce, Cardiff, United Kingdom
Robb Butler, Copenhagen, Denmark
Thomas Cherian, Geneva, Switzerland
Ron Dagan, Beer Sheva, Israel
Susanna Esposito, Perugia, Italy
Adam Finn, Bristol, United Kingdom
Barney Graham, Bethesda, United States
Katrine Habersaat, Copenhagen, Denmark
Willem Hanekom, Seattle WA, United States
Mark Hatherill, Cape Town, South Africa
Adrian Hill, Oxford, United Kingdom
Keith Paul Klugman, Seattle, WA, United States
Shamez Ladhani, London, United Kingdom
Richard Malley, Boston, United States
Federico Martinón-Torres, Santiago de Compostela, Spain
Liz Miller, London, United Kingdom
Harish Nair, Edinburgh, United Kingdom
Marie Norredam, Copenhagen, Denmark
Pekka Nuorti, Tampere, Finland
Miguel O´Ryan, Santiago, Chile
Stanley Plotkin, New York City, United States
Mario Poljak, Ljubljana, Slovenia
marco safadi, sao paulo, Brazil
Jonathan Van-Tam, Nottingham, United Kingdom
Marieke von der Werf, Solna, Sweden
Ole Wichmann, Berlin, Germany
Tom Wilkinson, Southhampton, United Kingdom

Contact Person (Scientific Programme)

Carla Seiler
Executive Office
P.O. Box 214
4010 Basel
+41 61 508 01 72

Administrative Secretariat

Matijana Milosevic
DT Croatia
Obala, Stiepana Radića 25
20000 Dubrovnik
+385 20 313 555

Venue Info

Event Map
Venue Details
Hotel Kompas
Ul. kardinala Stepinca 21, 20000 Dubrovnik

Friday, 8 September 2017

08:30 - 09:00
Opening of the Conference
Speaker(s): Ron Dagan
Speaker(s): Susanna Esposito
Speaker(s): Mario Poljak
09:00 - 10:45
Opening symposium: Equity in immunization
Chairperson(s): Robb Butler
Chairperson(s): Ron Dagan
09:00 - 09:25
Equity in health; principles and policy considerations
Speaker(s): Tammy Boyce
09:25 - 09:50
Inequalities in vaccine uptake among refugees and immigrants
Speaker(s): Marie Norredam
09:50 - 10:15
Defining health equity in relation to immunization
Speaker(s): Robb Butler
10:45 - 11:15
Coffee break
11:15 - 13:00
Vaccine-preventable diseases – exposing the gaps
Chairperson(s): Paolo Bonanni
Chairperson(s): Robb Butler
11:15 - 11:40
Measles and mumps
Speaker(s): Ole Wichmann
11:40 - 12:05
12:05 - 12:30
Speaker(s): Shamez Ladhani
13:00 - 14:15
Lunch break
14:15 - 16:00
Vaccines for new global threats
Chairperson(s): Susanna Esposito
Chairperson(s): Stanley Plotkin
14:15 - 14:40
Speaker(s): Barney Graham
14:40 - 15:05
Brazil catastrophe of Zika from the start to the current days
Speaker(s): marco safadi
16:00 - 16:30
Coffee break
16:30 - 18:15
Old foe – new solutions? Is a new tuberculosis vaccine still a dream?
Chairperson(s): Thomas Cherian
Chairperson(s): Willem Hanekom
16:30 - 16:55
Current epidemiology
Speaker(s): Marieke von der Werf
16:55 - 17:20
Current implementation
Speaker(s): Mark Hatherill
17:20 - 17:45
Novel vaccine horizons
Speaker(s): Willem Hanekom
18:30 - 20:30
Networking event

Saturday, 9 September 2017

08:30 - 10:15
Progress in RSV vaccines
Chairperson(s): Louis Bont
Chairperson(s): Susanna Esposito
08:30 - 08:55
New insights in RSV epidemiology
Speaker(s): Harish Nair
08:55 - 09:20
RSV vaccines to prevent disease in infants
Speaker(s): Louis Bont
09:20 - 09:45
RSV vaccines to prevent disease in adults
Speaker(s): Tom Wilkinson
10:15 - 10:45
Coffee break
10:45 - 12:05
Did we learn how to better communicate?
Chairperson(s): Robb Butler
Chairperson(s): Federico Martinón-Torres
10:45 - 11:10
Pandemic flu
Speaker(s): Jonathan Van-Tam
11:10 - 11:35
Speaker(s): Katrine Habersaat
12:05 - 13:20
Lunch break
13:20 - 14:40
New approaches for implementation of vaccines
Chairperson(s): Robb Butler
Chairperson(s): Ron Dagan
13:20 - 13:45
Childhood influenza vaccination also protects against disease in adults
Speaker(s): Adam Finn
13:45 - 14:10
Reduced dose PCV – is the world ready for it?
Speaker(s): Keith Paul Klugman
14:40 - 15:05
Non-specific effect of vaccines
Speaker(s): Federico Martinón-Torres
15:35 - 16:00
Endgame of Polio
Speaker(s): Ananda Bandyopadhyay

Sunday, 10 September 2017

08:30 - 10:40
New vaccines for old diseases
Chairperson(s): Adam Finn
Chairperson(s): Keith Paul Klugman
08:30 - 08:55
Speaker(s): Paolo Bonanni
08:55 - 09:20
Speaker(s): Stanley Plotkin
09:20 - 09:45
Speaker(s): Miguel O´Ryan
09:45 - 10:10
Speaker(s): Adrian Hill
10:40 - 11:10
Coffee break
11:10 - 12:30
Innovative approaches for vaccines against old diseases
Chairperson(s): Shamez Ladhani
Chairperson(s): Pekka Nuorti
11:10 - 11:35
Pneumococcal vaccines – beyond the current spectrum of polysaccharide antigens
Speaker(s): Richard Malley
11:35 - 12:00
Are we ready to accommodate the increasing number of new vaccines and the increasing number of target populations?
Speaker(s): Liz Miller
12:30 - 13:00
Closing remarks
13:00 - 14:15
Lunch break

Share and discuss your research with colleagues from around the world. Abstracts can be submitted from 6 June to 28 August 2017.
Please download the template and submit it by email to:
If you have any questions or need any assistance, please do not hesitate to contact us at

  • Before and on 1 June 2017: EUR 450
  • After 1 June 2017: EUR 550
  • Before and on 1 June 2017: EUR 650
  • After 1 June 2017: EUR 800
The registration fee includes the scientific sessions, printed conference material, lunches and coffee breaks, but not travel and accommodation costs.

ESCMID members can freely download the presentations given at the conference in our ESCMID eLibrary:
Click here
No certificate found